Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
160.40    -6.20 (-3.72%)
Bid:
161.00
Ask:
161.80
Spread: 0.80 (0.497%)
Market Cap: £795.46m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Debt Prospectus

23 Apr 2020 16:25

RNS Number : 7062K
Jupiter Fund Management PLC
23 April 2020
 

Publication of Prospectus

Jupiter Fund Management plc

23 April 2020

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

Publication of Prospectus

The following prospectus has been approved by the UK Listing Authority and is available for viewing:

Prospectus dated 23 April 2020 (the "Prospectus") relating to the Jupiter Fund Management plc issue of £50,000,000 8.875 per cent. Fixed Rate Reset Callable Subordinated Notes due 2030.

 A copy of the Prospectus is available for viewing at:

http://www.rns-pdf.londonstockexchange.com/rns/7062K_1-2020-4-23.pdf

 

For further information, please contact:

 

 

 

Investors

Media

 

 

Jupiter

Alex Sargent/Investor Relations

+44 (0)20 3817 1534/1065

Despina Constantinides/Corporate Communications

+44 (0)20 3817 1196/1278

 

 

 

 

Powerscourt

Justin Griffiths

+44 (0)20 7549 0999

 

 

 

 

 

 

 

 

 

       

 Important Notices

This announcement is an advertisement and for information only and does not constitute or form part of, and should not be construed as, an offer to sell nor is it a solicitation of an offer to buy securities in any jurisdiction where it is unlawful to do so.

The offering and the distribution of this announcement only to and directed only at persons in circumstances where sections 21(1) of the Financial Services and Markets Act 2000, as amended, does not apply (all such persons together being referred to as "relevant persons"). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity in the United Kingdom (including, but not limited to, any invitation, offer or agreement to subscribe, purchase or otherwise acquire securities) to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

PROHIBITION OF SALES TO EUROPEAN ECONOMIC AREA (THE "EEA") AND UNITED KINGDOM (THE "UK") RETAIL INVESTORS - The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA or in the UK. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive (EU) 2014/65 (as amended, "MiFID II"); or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or in the UK may be unlawful under the PRIIPs Regulation.

MIFID II product governance / Professional investors and ECPs only target market - Solely for the purposes of the manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a "distributor") should take into consideration the manufacturer's target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturer's target market assessment) and determining appropriate distribution channels.

This announcement is not an offer of securities for sale in the United States or in any other jurisdiction to whom or in which such offer or solicitation is unlawful and is not for publication or distribution to U.S. persons (within the meaning of Regulation S under the Securities Act). The Notes have not been and will not be registered under the Securities Act and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDIKKNBBPBKDQQB
Date   Source Headline
26th May 20231:11 pmRNSTR-1: Notification of major holdings
23rd May 20233:30 pmRNSDirector/PDMR Shareholding
10th May 20233:25 pmRNSResult of AGM
4th May 20236:00 pmRNSReplacement: Holding(s) in Company
2nd May 202312:41 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSNon-Executive Chair change and AGM update
25th Apr 20237:00 amRNSTrading Update and Notice of Results
20th Apr 20232:03 pmRNSHolding(s) in Company
6th Apr 20234:36 pmRNSNotification of Major Holdings
5th Apr 20233:05 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:07 pmRNSDirector/PDMR Shareholding
30th Mar 20232:30 pmRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202312:00 pmRNSDirector Declaration
30th Mar 20239:26 amRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSHolding(s) in Company
21st Mar 20233:39 pmRNSHolding(s) in Company
20th Mar 20234:14 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSResults for the year ended 31 December 2022
10th Feb 20232:07 pmRNSHolding(s) in Company
10th Feb 202310:34 amRNSHolding(s) in Company
9th Feb 20231:00 pmRNSStandard form for notification of major holdings
31st Jan 20235:33 pmRNSTotal Voting Rights
27th Jan 20239:58 amRNSHolding(s) in Company
20th Jan 20235:04 pmRNSBuyback Programme
19th Jan 20235:26 pmRNSTransaction in Own Shares
18th Jan 20235:41 pmRNSTransaction in Own Shares
17th Jan 20235:36 pmRNSTransaction in Own Shares
16th Jan 20235:39 pmRNSTransaction in Own Shares
13th Jan 20235:38 pmRNSTransaction in Own Shares
12th Jan 20235:17 pmRNSTransaction in Own Shares
11th Jan 20235:42 pmRNSTransaction in Own Shares
11th Jan 20231:41 pmRNSHolding(s) in Company
11th Jan 202311:51 amRNSHolding(s) in Company
10th Jan 20235:26 pmRNSTransaction in Own Shares
9th Jan 20235:25 pmRNSTransaction in Own Shares
9th Jan 20233:25 pmRNSHolding(s) in Company
9th Jan 202312:12 pmRNSHolding(s) in Company
6th Jan 20235:30 pmRNSTransaction in Own Shares
5th Jan 20235:29 pmRNSTransaction in Own Shares
4th Jan 20235:35 pmRNSTransaction in Own Shares
3rd Jan 20235:39 pmRNSTransaction in Own Shares
30th Dec 202211:30 amRNSTotal Voting Rights
22nd Dec 20227:30 amRNSUpdate on share buyback programme
21st Dec 20225:35 pmRNSTransaction in Own Shares
20th Dec 20226:00 pmRNSTransaction in Own Shares
19th Dec 20225:38 pmRNSTransaction in Own Shares
19th Dec 202211:58 amRNSHolding(s) in Company
16th Dec 20226:11 pmRNSTransaction in Own Shares
15th Dec 20225:37 pmRNSTransaction in Own Shares
15th Dec 20221:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.